As the new semester unfolds, Jiyan Biotech is thrilled to announce an extraordinary back-to-school promotion. This initiative aims to empower researchers with high-quality products at unbeatable prices, facilitating a productive start to their research endeavors.Key Highlights1. Organoid Construction Kit Mini Kit: Buy One, Get a 5mL Matrix Gel for Free!Comprehensive Solution: Our Organoid Construction Kit Mini Kit streamlines the entire process, encompassing tissue sampling, organoid culture, subculture, cryopreservation, and thawing.User-Friendly and High Success Rate: With a simplified protocol, this kit ensures an impressive success rate of over 90%, making it accessible even to those new to organoid research.Diverse Options: Choose from more than 40 human and murine organoid construction kits, catering to a wide range of experimental requirements.Beginner-Friendly Support: Our "ready-to-use" kits are designed for researchers of all levels. Encountering issues? Our exper...

Jiyan Biotech makes an appearance at the Annual Conference of Liver Disease New DrugsFrom December 13th to 14th, 2024, the 2024 Annual Meeting of the Liver Disease New Drug Alliance and the Symposium on Metabolic - Associated Fatty Liver Disease, co - hosted by the Liver Disease New Drug Alliance and YaoTimes, were successfully held in Shanghai. The event gathered over 30 liver disease experts and industry leaders from industry, academia, research, and investment. Centering on the theme "Seize the Opportunities of the Times and Conquer Stubborn Liver Diseases!", they delivered wonderful presentations.Metabolic - Associated Fatty Liver Disease（MAFLD）Fatty liver disease, or fatty liver for short, is marked by excessive fat accumulation and steatosis in hepatocytes. When a large quantity of fat is generated and cannot be promptly transported out of the liver, it accumulates in hepatocytes. Over time, fatty liver ensues.Metabolic - associated fatty liver disease (MAFLD) is the ...

In recent years, the biopharmaceutical industry has witnessed a diverse range of fortunes, with an overall sense of chill. After everyone has come to realize that the cold winter is unlikely to fade away on its own in the short term, it becomes particularly crucial to strive for ways to "break the situation."The 2024 Distrimap Scientific Research Tools Innovation and Development and Distribution Channel Conference and the Scientific Research Tools Industry Chain Exhibition successfully concluded in Shanghai on December 7th. Manufacturers of reagents, instruments, consumables, and innovative technologies in the biopharmaceutical industry, as well as channel distributors, engaged in comprehensive exchanges and dialogues. Jiyan Biotech was invited to participate and presented a sincere communication and report to distributors and industry peers. Jiyan Biotech's Keynote Speech: How to Be the First to "Seize the Opportunity"? At present, the sub - fields of organoids...

The 2024 Distrimap Scientific Research Tools Innovation, Development, and Distribution Channel Conference, along with the Scientific Research Tools Industry Chain Exhibition, will be held at the Crowne Plaza Shanghai Pujiang, Shanghai Construction Engineering on December 7th (this Saturday). Jiyan Biotech cordially invites you to attend. We will comprehensively showcase and introduce the high - quality products and services provided by Jiyan Biotech.Jiyan Biotech is dedicated to the construction of tumor organoid models and the development of organ - on - a - chip technology platforms. These are used for drug sensitivity testing, drug evaluation, potential target research, and the study of tumor disease mechanisms. It provides personalized and precise treatment strategies for patients and offers a novel in - vitro evaluation model for new drug discovery and development.We welcome new and existing customers, as well as agents, to visit Booth #C26!Come and learn about our products and se...

On December 17 local time, MilliporeSigma, the life sciences business unit of German pharmaceutical and chemical giant Merck Group, announced that it would complete the acquisition of HUB Organoids, an internationally recognized pioneer in organoid research and development, by the end of 2024. This has undoubtedly created a huge stir in the organoid market.Officials said that through this acquisition, Merck aims to expand its portfolio of 2D and 3D cell culture products. As the fastest - growing area in cell culture, organoids have the potential to accelerate drug development and reduce animal testing.Jean - Charles Wirth, Head of Science and Laboratory Solutions at Merck Life Science, said, "For researchers committed to adopting new approaches to treat today's most challenging diseases, organoids provide important insights into biological systems. We look forward to enabling scientists to obtain solutions from samples more quickly and conveniently."The application prospe...

Jiyan has always been adhering to the user-centered, to provide users with more professional, more intuitive, richer and more convenient service experience, we have upgraded the website, now officially released!On the occasion of this new website upgrade, we have launched the “Buy and Give” activity, which includes a series of small and exquisite products developed by JIYAN, as well as JIYAN's selected gifts, the activity is limited to a period of 3 weeks. The campaign is limited to 3 weeks, so you won't be left wanting for more, there is always one that suits you.Poster for more details:Hurry up and contact us!Add sales wechat: 139 1378 9040

In order to bring convenient and high-quality products and services to more researchers, we are now sincerely inviting agents from all regions to join us. We are committed to expanding the organoid reagent and service business!Why US? Diverse Product RangeOver 50 organoid construction kits from sources like tumors, normal tissues and mice.Favorable Agency TermsProduct - advantage discounts, full - line promotional support, online team training, joint campus tours, and promotional materials support.Solid Technical FoundationWe provide on - site technical guidance in the market and are the only one to promise free reconstruction in case of failure.Exclusive Market ProductsSE-gel, a specialized tissue embedding gel for organoids, is an exclusive product in the market.For more information, please feel free to contact us. Tel: +86 139 1378 9040ABOUT Jiyan BiotechJiyan Biotech, based in Suzhou, is dedicated to the realm of tumor precision medical services. It focuses on the development of tu...

Jiyan Biotech has been granted a patent titled "A Bionic Intestinal Organ-on-a-Chip" (Authorization Announcement No. CN221720838U), with an application date of August 2024, which can rapidly cultivate a variety of bionic intestinal microstructures.The patent abstract reveals that this utility model pertains to a bionic intestinal organ - on - a - chip, comprising a chip body with a hydrogel chamber. The hydrogel chamber measures 0.5 - 3 cm in length, 0.5 - 3 cm in width, and 0.1 - 3 mm in height. It connects to a hydrogel inlet at one end and a hydrogel outlet at the other.Inside the chamber, a patterned 3D hydrogel scaffold is formed from photocurable hydrogel via a patterning mask. A cell seeding channel links to the chamber for cell inoculation into the 3D scaffold. Multiple fence - like microstructures on the chamber's sidewall connect it to two culture medium channels, each 0.5 - 4 cm long. This utility model enables rapid cultivation of diverse bionic intestinal mic...

On October 10, 2024, the Center for Drug Evaluation (CDE) of the National Medical Products Administration released the "Notice on Soliciting Opinions on the Technical Guidelines for Model - Guided R & D of Rare Disease Drugs (Draft for Comment)". The draft clearly states that due to the particularity nature of rare diseases, non - clinical research data in the R & D of rare disease drugs include, but are not limited to, gene, molecular, cell, organoid, organ - on - a - chip, and animal research data. It also emphasizes that the basis for dose selection in clinical research can be derived from animal research and /or in - vitro research results such as organoids and molecules.Jiyan Biotech positions itself in the field of precision oncology medical services. It focuses on the construction of tumor organoid models and the development of organ - on - a - chip technology platforms, which are applied to drug sensitivity testing, drug evaluation, research on potential targe...

On April 25th, Dr. Liu Jinxia, an associate chief physician in the Department of Gastroenterology at Affiliated Hospital of Nantong University, collaborated with the team led by Prof. Rajiv Jalan from University College London (UCL) and Royal Free Hospital in the UK. They published an original research article titled "Clinical, experimental and pathophysiological effects of Yaq - 001: a non - absorbable, gut - restricted adsorbent in models and patients with cirrhosis" in Gut, a top journal in gastroenterology (IF: 24.5). Liu Jinxia is the first author of this article. The article proposes a new concept of using the novel activated carbon beads Yaq - 001 for the prevention and treatment of cirrhosis and acute - on - chronic liver failure. (Reposted from the official website of Affiliated Hospital of Nantong University)In - vivo Experiments in MiceThe research team developed a novel non - absorbable, gut - restricted activated carbon bead, Yaq - 001, which can rapidly adsorb ...

New Product Release of Jiyan BiotechSpecialized Tissue Embedding Gel for Organoids (SE-Gel)Jiyan Biotech focuses on the field of precision oncology medical services, committed to the construction of tumor organoid models and the development of related chips. In scientific research, after the successful construction of organoids, it is necessary to conduct tissue morphology and specific marker identification. During this process, the technical challenges in embedding lie in embedding and sectioning. Traditional embedding methods that require high - temperature heating involve complex melting and solidification processes, with difficult - to - master time control, demanding constant attention. When using paraffin embedding, due to the small size of organoids, they are extremely likely to be lost, making it difficult to obtain satisfactory tissue sections, and it is hard to locate the target tissue after sectioning.To address the above pain points, Jiyan Biotech has launched SE - ...